Literature DB >> 7523975

Immersion and perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) compared to mitochondrial enzymes 6 hours after MCA-occlusion in primates.

C Dettmers1, A Hartmann, T Rommel, S Krämer, S Pappata, A Young, S Hartmann, S Zierz, E T MacKenzie, J C Baron.   

Abstract

2,3,5-triphenyltetrazolium chloride (TTC) is commonly applied in rodents and cats as a marker of infarcted tissue as early as 20 min after the onset of focal ischaemia. At this stage it is suggested that it reflects hypoperfusion rather than failure of respiratory chain. Immersion of brain slices in TTC solution is preferable in comparison to perfusion with TTC in order to ensure, that enough TTC enters the post-occlusion tissue. We compared immersion technique versus perfusion technique 6 h after permanent occlusion of the left middle cerebral artery in 18 baboons. In addition, we assessed the function of the respiratory chain enzymes of stained and unstained tissue in three baboons. The immersion technique revealed an absence of TTC staining limited to subcortical structures in two animals. In seven experiments TTC indicated involvement of almost the entire MCA territory. The extent of the ischaemic lesion indicated by the perfusion technique was very similar. Tissue samples from the presumed infarcted areas revealed normal mitochondrial function. We conclude that perfusion and immersion technique do not cause significant different ischaemic delineation 6 h after middle cerebral artery occlusion. TTC staining appears to be a reliable method of evaluating volume of infarction in primates. Furthermore, absence of TTC staining 6 h after stroke onset is caused by energy or oxygen depletion rather than by mitochondrial injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523975     DOI: 10.1080/01616412.1994.11740228

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  8 in total

1.  Mannitol-facilitated perfusion staining with 2,3,5-triphenyltetrazolium chloride (TTC) for detection of experimental cerebral infarction and biochemical analysis.

Authors:  Yu-Yo Sun; Dianer Yang; Chia-Yi Kuan
Journal:  J Neurosci Methods       Date:  2011-10-01       Impact factor: 2.390

2.  The amnestic agent anisomycin disrupts intrinsic membrane properties of hippocampal neurons via a loss of cellular energetics.

Authors:  C J Scavuzzo; M J LeBlancq; F Nargang; H Lemieux; T J Hamilton; C T Dickson
Journal:  J Neurophysiol       Date:  2019-07-10       Impact factor: 2.714

3.  RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION).

Authors:  Shimin Liu; Gehua Zhen; Bruno P Meloni; Kym Campbell; H Richard Winn
Journal:  J Exp Stroke Transl Med       Date:  2009-01-01

4.  Transient cerebral ischemia. Association of apoptosis induction with hypoperfusion.

Authors:  Z S Vexler; T P Roberts; A W Bollen; N Derugin; A I Arieff
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  Dexmedetomidine-induced cerebral hypoperfusion exacerbates ischemic brain injury in rats.

Authors:  Takaaki Nakano; Hirotsugu Okamoto
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

6.  Altered expression of thrombospondin-1/-2 in the cortex and synaptophysin in the hippocampus after middle cerebral artery occlusion and reperfusion.

Authors:  Yu Wang; Wei Chen; Bin Hou; Yan Gao; Zhihui Li; Xu Li; Chenggang Zhang
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

7.  A Comparative Study of Variables Influencing Ischemic Injury in the Longa and Koizumi Methods of Intraluminal Filament Middle Cerebral Artery Occlusion in Mice.

Authors:  Gary P Morris; Amanda L Wright; Richard P Tan; Amadeus Gladbach; Lars M Ittner; Bryce Vissel
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

8.  Developmental exposure to polychlorinated biphenyls influences stroke outcome in adult rats.

Authors:  Suzan Dziennis; Dongren Yang; Jian Cheng; Kim A Anderson; Nabil J Alkayed; Patricia D Hurn; Pamela J Lein
Journal:  Environ Health Perspect       Date:  2008-04       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.